Researcher Profile

Researcher Profile

Henry Wagner Jr., MD

Henry Wagner Jr., MD

Professor, Department of Radiation Oncology
Professor, Department of Medicine
Professor, Department of Radiology
Scientific Program:Next-Generation Therapies
Disease Teams:
Bone Marrow Transplantation
Central Nervous System Cancer
Leukemia and Lymphoma
Melanoma and Skin Cancer
Thoracic Cancer
huw3@psu.edu

Research Interests

  • Radiotherapy
  • Therapeutics
  • Non-Small Cell Lung Carcinoma
  • Survival
  • Drug Therapy
  • Small Cell Lung Carcinoma
  • Thorax
  • Neoplasms
  • Cisplatin
  • Radiation
  • Neoplasm Metastasis
  • Etoposide

Clinical Trials

A Randomized Phase II Trial of Brentuximab Vedotin (SGN35, NSC# 749710), or Crizotinib (NSC#749005, Commercially Labeled) in Combination With Chemotherapy for Newly Diagnosed Patients With Anaplastic Large Cell Lymphoma (ALCL)

Recent Publications

2017

Koller, KM, Mackley, HB, Liu, J, Wagner, H, Talamo, G, Schell, TD, Pameijer, C, Neves, RI, Anderson, B, Kokolus, KM, Mallon, CA & Drabick, JJ 2017, 'Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone', Cancer Biology and Therapy, vol. 18, no. 1, pp. 36-42. https://doi.org/10.1080/15384047.2016.1264543

2016

Al-Marrawi, MY, Mackley, HB, Ali, S, Wagner, H, Joshi, M, Holder, S, Kaag, M, Mallon, C, Talamo, G & Drabick, JJ 2016, 'Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and Review', Clinical Genitourinary Cancer, vol. 14, no. 4, pp. e393-e399. https://doi.org/10.1016/j.clgc.2016.01.004

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)